BioViva Supports Patient Advocacy For Gene Therapy

30 March 2017

“Patient advocates are the driving force behind the development of many new drugs and amendments to medical regulations. It is the common man and...

Read more

Dual Gene Therapy Has Beneficial Effects On Blood Biomarkers And Muscle Composition

2 March 2017

In April 2016 BioViva USA Inc. published a press release stating that Elizabeth Parrish, CEO, had experienced telomere lengthening in her leukocytes, as a...

Read more

One Year Anniversary Of Bioviva’s Gene Therapy Against Human Aging

2 March 2017

It has officially been one year since I volunteered to take the first gene therapy to treat biological aging. It has been an amazing...

Read more

Gene Therapy For Sickle Cell Disease Passes Key Preclinical Test

7 September 2016

A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell...

Read more

Bioviva, Gene Therapy And Blockchain Merges In Russia

2 September 2016

During June 20th to the 23rd, founder and CEO of BioViva USA Inc, Elizabeth Parrish visited Moscow at the invitation of board member of...

Read more

First Patent Application For Dual Gene Therapy Targeting The Aging Process

20 June 2016

BioViva USA Inc. files for patent for dual gene therapy to restore telomere attrition and muscle degradation caused by aging In 2015 the CEO...

Read more

Bioviva Talks At The 2b Ahead Thinktank Future Congress In Germany

18 June 2016

The 2b AHEAD ThinkTank Future Congress ranks as one of the most attractive events in the European innovation scene. For the last 15 years,...

Read more

First Gene Therapy Successful Against Human Aging

21 April 2016

American woman gets biologically younger after gene therapies Elizabeth Parrish, CEO of Bioviva USA Inc. has become the first human being to be successfully...

Read more

Deep Knowledge Life Sciences And Bioviva Announce Partnership

19 April 2016

London-based investment fund brings Seattle-based biotech startup into its portfolio. London, U.K., 19 April 2016 Summary: Seattle-based biotech startup BioViva USA Inc. and London-based...

Read more